The RNA-binding protein repertoire of embryonic stem cells

2013 ◽  
Vol 20 (9) ◽  
pp. 1122-1130 ◽  
Author(s):  
S Chul Kwon ◽  
Hyerim Yi ◽  
Katrin Eichelbaum ◽  
Sophia Föhr ◽  
Bernd Fischer ◽  
...  
Cell Reports ◽  
2021 ◽  
Vol 35 (9) ◽  
pp. 109198
Author(s):  
Shlomi Dvir ◽  
Amir Argoetti ◽  
Chen Lesnik ◽  
Mark Roytblat ◽  
Kohava Shriki ◽  
...  

2009 ◽  
Vol 29 (7) ◽  
pp. 1855-1868 ◽  
Author(s):  
Ana Artero-Castro ◽  
Francisco B. Callejas ◽  
Josep Castellvi ◽  
Hiroshi Kondoh ◽  
Amancio Carnero ◽  
...  

ABSTRACT Embryonic stem cells are immortalized cells whose proliferation rate is comparable to that of carcinogenic cells. To study the expression of embryonic stem cell genes in primary cells, genetic screening was performed by infecting mouse embryonic fibroblasts (MEFs) with a cDNA library from embryonic stem cells. Cold-inducible RNA-binding protein (CIRP) was identified due to its ability to bypass replicative senescence in primary cells. CIRP enhanced extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation, and treatment with an MEK inhibitor decreased the proliferation caused by CIRP. In contrast to CIRP upregulation, CIRP downregulation decreased cell proliferation and resulted in inhibition of phosphorylated ERK1/2 inhibition. This is the first evidence that ERK1/2 activation, through the same mechanism as that described for a Val12 mutant K-ras to induce premature senescence, is able to bypass senescence in the absence of p16INK4a, p21WAF1, and p19ARF upregulation. Moreover, these results show that CIRP functions by stimulating general protein synthesis with the involvement of the S6 and 4E-BP1 proteins. The overall effect is an increase in kinase activity of the cyclin D1-CDK4 complex, which is in accordance with the proliferative capacity of CIRP MEFs. Interestingly, CIRP mRNA and protein were upregulated in a subgroup of cancer patients, a finding that may be of relevance for cancer research.


2006 ◽  
Vol 48 (6) ◽  
pp. 381-390 ◽  
Author(s):  
Tetsuya S. Tanaka ◽  
Isabel Lopez de Silanes ◽  
Lioudmila V. Sharova ◽  
Hidenori Akutsu ◽  
Toshiyuki Yoshikawa ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (8) ◽  
pp. e72300 ◽  
Author(s):  
Sharmila Fagoonee ◽  
Claudia Bearzi ◽  
Ferdinando Di Cunto ◽  
John G. Clohessy ◽  
Roberto Rizzi ◽  
...  

2013 ◽  
Vol 40 (7) ◽  
pp. 4391-4396 ◽  
Author(s):  
Meghdad Yeganeh ◽  
Ehsan Seyedjafari ◽  
Farnaz Akbari Kamrani ◽  
Nasser Ghaemi

Stem Cells ◽  
2011 ◽  
Vol 29 (10) ◽  
pp. 1504-1516 ◽  
Author(s):  
Habiba Elatmani ◽  
Virginie Dormoy-Raclet ◽  
Pierre Dubus ◽  
François Dautry ◽  
Claire Chazaud ◽  
...  

2005 ◽  
Vol 25 (12) ◽  
pp. 4881-4891 ◽  
Author(s):  
Diana L. Carlone ◽  
Jeong-Heon Lee ◽  
Suzanne R. L. Young ◽  
Erika Dobrota ◽  
Jill Sergesketter Butler ◽  
...  

ABSTRACT Cytosine methylation at CpG dinucleotides is a critical epigenetic modification of mammalian genomes. CpG binding protein (CGBP) exhibits a unique DNA-binding specificity for unmethylated CpG motifs and is essential for early murine development. Embryonic stem cell lines deficient for CGBP were generated to further examine CGBP function. CGBP − / − cells are viable but show an increased rate of apoptosis and are unable to achieve in vitro differentiation following removal of leukemia inhibitory factor from the growth media. Instead, CGBP − / − embryonic stem cells remain undifferentiated as revealed by persistent expression of the pluripotent markers Oct4 and alkaline phosphatase. CGBP − / − cells exhibit a 60 to 80% decrease in global cytosine methylation, including hypo-methylation of repetitive elements, single-copy genes, and imprinted genes. Total DNA methyltransferase activity is reduced by 30 to 60% in CGBP − / − cells, and expression of the maintenance DNA methyltransferase 1 protein is similarly reduced. However, de novo DNA methyltransferase activity is normal. Nearly all aspects of the pleiotropic CGBP − / − phenotype are rescued by introduction of a CGBP expression vector. Hence, CGBP is essential for normal epigenetic modification of the genome by cytosine methylation and for cellular differentiation, consistent with the requirement for CGBP during early mammalian development.


2005 ◽  
Vol 306 (2) ◽  
pp. 349-356 ◽  
Author(s):  
Hideyuki Okano ◽  
Hironori Kawahara ◽  
Masako Toriya ◽  
Keio Nakao ◽  
Shinsuke Shibata ◽  
...  

2019 ◽  
Author(s):  
Isabelle Leticia Zaboroski Silva ◽  
Anny Waloski Robert ◽  
Guillermo Cabrera Cabo ◽  
Lucia Spangenberg ◽  
Marco Augusto Stimamiglio ◽  
...  

AbstractPosttranscriptional regulation plays a fundamental role in the biology of embryonic stem cells (ESCs). Many studies have demonstrated that multiple mRNAs are coregulated by one or more RNA binding proteins (RBPs) that orchestrate the expression of these molecules. A family of RBPs, known as PUF (Pumilio-FBF), is highly conserved among species and has been associated with the undifferentiated and differentiated states of different cell lines. In humans, two homologs of the PUF family have been found: Pumilio 1 (PUM1) and Pumilio 2 (PUM2). To understand the role of these proteins in human ESCs (hESCs), we first demonstrated the influence of the silencing of PUM1 and PUM2 on pluripotency genes. OCT4 and NANOG mRNA levels decreased significantly with the knockdown of Pumilio, suggesting that PUMILIO proteins play a role in the maintenance of pluripotency in hESCs. Furthermore, we observed that the hESCs silenced for PUM1 and 2 exhibited an improvement in efficiency of in vitro cardiomyogenic differentiation. Using in silico analysis, we identified mRNA targets of PUM1 and PUM2 expressed during cardiomyogenesis. With the reduction of PUM1 and 2, these target mRNAs would be active and could be involved in the progression of cardiomyogenesis.


Sign in / Sign up

Export Citation Format

Share Document